INmune Bio
INMB
7 hedge funds and large institutions have $375K invested in INmune Bio in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
40% more funds holding
Funds holding: 5 → 7 (+2)
7% more capital invested
Capital invested by funds: $352K → $375K (+$23K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.14% less ownership
Funds ownership: 0.52% → 0.37% (-0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$29K |
| 2 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
+$10.1K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$8.12K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$2.02K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$1.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$80K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.33K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $324K | – | – | – |
|
|
2
BlackRock
New York
| $29K | +$29K | +2,864 | +1,557% |
|
|
TPWA
3
TRUE Private Wealth Advisors
Salem,
Oregon
| $9K | +$10.1K | +1,000 | New |
|
|
4
Bank of America
Charlotte,
North Carolina
| $8K | +$8.12K | +802 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $2K | -$9.33K | -922 | -76% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $2K | +$2.02K | +200 | New |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$1.01K | +100 | New |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$80K | -10,191 | Closed |
|
|
FIA
9
FNY Investment Advisers
New York
| – | -$1K | -200 | Closed |
|
INMB Hedge Fund Activity: Q2 2019 in Review
7 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q2 2019, worth a combined $375K — up 6.5% from $352K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new INMB positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, adding an estimated $29K. The largest seller was Citadel Advisors, exiting entirely with an estimated $80K sold.
- 7 institutional investors held INmune Bio (INMB) as of Q2 2019, up from 5 in Q1 2019.
- Funds reported $375K of INmune Bio stock for Q2 2019, up 6.5% quarter-over-quarter.
- 4 funds opened new INmune Bio positions in Q2 2019 and 2 closed out, a net change of +2 holders.
- The largest INmune Bio buyer in Q2 2019 was BlackRock, an estimated $29K added.
- The largest INmune Bio seller in Q2 2019 was Citadel Advisors, an estimated $80K sold.
Based on aggregated 13F filings for Q2 2019.